<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NAS:XFOR (USA)

X4 Pharmaceuticals Inc $ 12.37 0.16 (1.31%)

Volume:
11,183
Avg Vol (1m):
29,740
Market Cap $:
153.77 Mil
Enterprise Value $:
92.72 Mil
P/E (TTM):
0.00
P/B:
1.65
Warning! GuruFocus has detected with XFOR. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

Financial Strength

3.4/10
Current Vs Industry Vs History
Cash-To-Debt 3.1
Debt-to-Equity 0.3
Debt-to-EBITDA -0.68
N/A
Altman Z-Score 1.17
DISTRESS
GREY
SAFE

Profitability

1/10
Current Vs Industry Vs History
Operating Margin % -1255.8
Net Margin % -1271.83
ROE % -105.95
ROA % -66.4
ROC (Joel Greenblatt) % -3376.43
3-Year EBITDA Growth Rate -9.6
N/A
3-Year EPS without NRI Growth Rate -8.2
N/A

Ratios

Current Vs Industry Vs History
PB Ratio 1.65
PS Ratio 8.46
EV-to-EBIT -2.14
N/A
EV-to-EBITDA -2.14
N/A
EV-to-Revenue 26.49
Current Ratio 7.32
Quick Ratio 7.32
Days Sales Outstanding 161.85

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -37
N/A

Valuation & Return

Current Vs Industry Vs History
Price-to-Tangible-Book 2.54
Price-to-Median-PS-Value 0.77
Earnings Yield (Greenblatt) % -46.45